Description
PRINCIPIO ACTIVO: GLIMEPIRIDA
No administrar dentro de las 14 horas previas a la quimioterapia
Evitar uso en presencia de tumores activos
Aumento de peso
SUSTANCIA: SCABISAN CMA
COMBODART 0.5/0.4MG 30 CAPS LABORATORIOS ALFASIGMA MEXICO SA DE CV PRINCIPIO ACTIVO: GLIMEPIRIDASUSTANCIA: COMBODART CAP. 0. 5 0. 4 MG. CAJA C FCO. C 30 FABRICANTE: GLAXO SMITH KLINE
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
